News for OLIPASS Corporation (244460.KQ)

The rising demand for anti-aging products is driven by an aging population and a growing awareness of skincare and wellness, fueled by various media...

The NSAIDs market is experiencing significant growth due to the rising incidence of chronic pain and inflammatory conditions such as arthritis and...

The surge in demand for orthopedic splints is primarily driven by several factors. These include the increasing prevalence of musculoskeletal disorders, a...

WASHINGTON, Sept. 29, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. and OliPass Corporation today announced that they have entered into a research and development collaboration agreement to... | September 29, 2022

/PRNewswire/ -- OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced that the dosing of pain killer...

SEOUL, South Korea, Oct. 25, 2021 /PRNewswire/ -- OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeut...